Boston Cambridge Biotech Networks Featured News

Boston Cambridge Biotech Networks News

• 

  BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR TEXAS MEMBERS AFFECTED BY SEVERE WEATHER

  January 27, 2023 Comments Off on BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR TEXAS MEMBERS AFFECTED BY SEVERE WEATHER

• 

  Bristol Myers, Charles River join Series A funding for iVexSol

  January 27, 2023 Comments Off on Bristol Myers, Charles River join Series A funding for iVexSol

• 

  STAT+: After bullying allegations, Eric Lander will return to run a lab at the Broad Institute

  January 27, 2023 Comments Off on STAT+: After bullying allegations, Eric Lander will return to run a lab at the Broad Institute

• 

  Questions raised about PFAS in period products

  January 27, 2023 Comments Off on Questions raised about PFAS in period products

• 

  Startups led by MIT mechanical engineers offer health care solutions

  January 27, 2023 Comments Off on Startups led by MIT mechanical engineers offer health care solutions

• 

  Former Lt. Gov. Polito joins advisory board of Firefly Health

  January 27, 2023 Comments Off on Former Lt. Gov. Polito joins advisory board of Firefly Health

• 

  Regel Therapeutics details its proprietary T3 platform and development pipeline on its newly launched website, expands its Board of Directors and announces its Scientific Advisory Board.

  January 27, 2023 Comments Off on Regel Therapeutics details its proprietary T3 platform and development pipeline on its newly launched website, expands its Board of Directors and announces its Scientific Advisory Board.

• 

  Marengo Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of its Novel TCR Vβ Directed Antibody-Fusion Molecule STAR0602, in Cancer Patients Refractory to Anti-PD1 Therapy

  January 27, 2023 Comments Off on Marengo Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of its Novel TCR Vβ Directed Antibody-Fusion Molecule STAR0602, in Cancer Patients Refractory to Anti-PD1 Therapy

• 

  Form D Friday: Plant-based chefs, keto bar makers attract more green

  January 27, 2023 Comments Off on Form D Friday: Plant-based chefs, keto bar makers attract more green

• 

  Economic outlook: Boston business leaders peer into the crystal ball

  January 27, 2023 Comments Off on Economic outlook: Boston business leaders peer into the crystal ball